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Abstract
The early postnatal period is a unique time of brain development, as diminishing amounts of neurogenesis coexist
with waves of gliogenesis. Understanding the molecular regulation of early postnatal gliogenesis may provide clues
to normal and pathological embryonic brain ontogeny, particularly in regards to the development of astrocytes and
oligodendrocytes. Cyclin dependent kinase 5 (Cdk5) contributes to neuronal migration and cell cycle control during
embryogenesis, and to the differentiation of neurons and oligodendrocytes during adulthood. However, Cdk5’s
function in the postnatal period and within discrete progenitor lineages is unknown. Therefore, we selectively
removed Cdk5 from nestin-expressing cells and their progeny by giving transgenic mice (nestin-CreERT2/R26R-
YFP/CDK5flox/flox [iCdk5] and nestin-CreERT2/R26R-YFP/CDK5wt/wt [WT]) tamoxifen during postnatal (P) days P2-P 4
or P7-P 9, and quantified and phenotyped recombined (YFP+) cells at P14 and P21. When Cdk5 gene deletion was
induced in nestin-expressing cells and their progeny during the wave of cortical and hippocampal gliogenesis (P2-
P4), significantly fewer YFP+ cells were evident in the cortex, corpus callosum, and hippocampus. Phenotypic
analysis revealed the cortical decrease was due to fewer YFP+ astrocytes and oligodendrocytes, with a slightly
earlier influence seen in oligodendrocytes vs. astrocytes. This effect on cortical gliogenesis was accompanied by a
decrease in YFP+ proliferative cells, but not increased cell death. The role of Cdk5 in gliogenesis appeared specific
to the early postnatal period, as induction of recombination at a later postnatal period (P7-P9) resulted in no change
YFP+ cell number in the cortex or hippocampus. Thus, glial cells that originate from nestin-expressing cells and their
progeny require Cdk5 for proper development during the early postnatal period.
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Introduction
Dysregulation of oligodendrocytes and astrocytes is
implicated in a growing number of neurological disorders [1–3].
Understanding the molecular underpinnings that regulate glia
during both normal and pathological development will be
important in developing future avenues for early diagnosis and
treatment of these disorders. While much is known about the
molecular control of glia during embryogenesis [4], less is
known about the molecular control of glia during early postnatal
development. This is in part due to the challenges of dissecting
such molecular mechanisms during a period when
oligodendrocytes and astrocytes continue to proliferate and
migrate well after the generation and migration of most neurons
are complete [5].
Some general aspects of glia development during the early
postnatal period have been established. For example,
postnatal astrocytes and oligodendrocytes emerge from a
variety of precursors, including radial glial cells, glioblasts in the
subventricular zone, oligodendrocytic-specific progenitors, and
– in some brain regions like the cerebral cortex – local sources
[6–10]. Oligodendrocytes populate the brain in several waves,
with the first two waves starting at embryonic day (E) 12.5 and
E16.5, respectively, and the last cell wave starting at birth (P0)
and lasting through the first few postnatal weeks (until ~P14)
[6,11,12]. In contrast to oligodendrogenesis, astrogliogenesis is
less understood, likely due to a lack of cell markers specific to
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astrocytic precursors [4]. However, astrocytic precursors
appear to emerge from radial glia cells that enter different brain
regions also during the early postnatal period (e.g. P0-P7)
[4,13–15]. Given that oligodendrocyte and astrocyte precursors
express the nestin early in development [6,15,16] and that
several lines of nestin-inducible fate-tracking mice exist [17], it
is notable that to-date no studies have specifically targeted the
early postnatal period to assess glial progeny from nestin-
expressing cells. In addition, few studies have used inducible
gene deletion approaches to assess the molecular basis of
early postnatal gliogenesis.
One of the most important regulators of neuronal
development is cyclin-dependent kinase 5 (Cdk5). During
embryogenesis and early life, this kinase regulates cell cycle
reentry and neuronal migration [18–20]. During adulthood,
Cdk5 is critical for neuronal differentiation and proper dendritic
morphology in the hippocampal neurogenic niche, the
subgranular zone [21,22]. In addition to its role in neuronal
development, correlative and in vitro evidence suggests Cdk5
may also be involved in glial development. For example, Cdk5
is expressed in both oligodendrocytes and astrocytes [23],
phosphorylates the astrocytic protein GFAP in vitro, and
appears to be important for the astrocyte cytoskeletal dynamics
[24,25]. However, direct evidence for the role of Cdk5 in
astrocytes and oligodendrocytes is limited. For example,
nothing is known about the role of Cdk5 in normal astrogenesis
in vivo during early life. Cdk5’s role in oligodendrocytes is
slightly better understood; in vitro it appears critical for their
migration and their differentiation [26–28], and in vivo it is
critical for their differentiation [29]. As with astrocytes, relatively
little is understood about the specific role of Cdk5 in early
postnatal oligodendrogenesis.
To investigate the role of Cdk5 in early postnatal brain
development and gliogenesis in particular, we employed our
nestin-CreERT2 mice [30,31] and Cre recombinase-sensitive
Cdk5 mice [32] to allow inducible deletion of Cdk5 from nestin-
expressing cells and their progeny during the postnatal
development in mice. Cdk5 is expressed in oligodendrocytes
and astrocytes [23], nestin-expressing progenitors can
generate oligodendrocytes, astrocytes, stem cells, and neurons
[6,15], and Cdk5 is critical for the proliferation and survival
during development [33]. Therefore, we hypothesized that
tamoxifen(Tam)-induced deletion of Cdk5 in nestin-expressing
cells and their progeny during the early postnatal period would
diminish glial production from nestin-expressing cells. In
keeping with our hypothesis, inducible deletion of Cdk5 from
nestin-expressing cells led to fewer recombined astrocytes and
oligodendrocytes in the cortex, hippocampus, and corpus
callosum. The role of Cdk5 in gliogenesis was restricted to
early life, as inducible deletion after the first postnatal week had
no effect on recombined cells. These data suggest glial cells
originating from nestin-expressing cells and their progeny
require Cdk5 for proper development during the early postnatal
period.
Methods
Animals and Ethics Statement
All experiments were approved by the Institutional Animal
Use and Care Committee at UT Southwestern (UTSW) Medical
Center (Permit Number: APN 0960-07-02-1). Nestin-CreERT2
and CDK5flox/flox mice – both previously published and
characterized [31,32] – were bred at UTSW; Nestin-CreERT2
mice are also available via Jackson Laboratories (strain
#016261). R26R-YFP mice – a widely-used Cre recombinase
reporter line (strain #006148 [34]) – were received from
Jackson Laboratories and bred at UTSW. Mice were
genotyped as previously described [21]. All mice were group-
housed in a UTSW vivarium accredited by the Association for
Assessment and Accreditation of Laboratory Animal Care
(AAALAC), and were kept on a 12-hour (hrs) light/dark cycle
with ad libitum access to food and water. Mice were first bred
to generate fathers homozygous for nestin-CreERT2 and
hemizygotic for Cdk5 flanked by loxP (floxed) sites (Cdk5flox/wt),
and mothers homozygous for the reporter transgene R26R-
YFP and hemizygotic for Cdk5 (Cdk5flox/wt). Pairing of these
parents resulted in expected litters according to Mendelian
ratios, including 25% wildtype (WT; nestin-CreERT2/R26R-
YFP/Cdk5wt/wt) and 25% nestin-inducible knockout mice (iCdk5;
nestin-CreERT2/R26R-YFP/Cdk5flox/flox). Thus, WT and iCdk5
littermates were used for quantitative comparison at a single
timepoint analysis (e.g. P14 or P21), with different litters used
for different timepoints. As the primary comparisons for this
manuscript were between WT and iCdk5 mice, only qualitative
analyses were performed between timepoints (e.g. P14 vs.
P21). While most experiments in this study used WT and iCdk5
littermates, one pilot experiment used nestin-CreERT2/R26R-
YFP (nestin-YFP) littermates to assess effectiveness of
different Tam administration paradigms (Fig. S1). For all
studies presented here, pups were sacrificed via decapitation
at P14 or P21, a procedure approved by the UTSW Institutional
Animal Care and Use Committee.
Drug Administration
Mice were given Tam (Sigma; 30 mg/ml of 10% ethanol and
90% sunflower oil) in 2 different paradigms [35,36]. For pilot
studies (Figure S1), Tam (150 mg/kg) was given only to
lactating mothers (termed “Tam to mother”, or “TOM”) via 1
daily intraperitoneal (i.p.) injection for 3 days when the pups
were P2-P4. For all other experiments, Tam was given to
mothers and to pups (“TOM-TOP”) of WT and iCdk5 mice, with
mothers receiving the daily i.p. injections and pups receiving
daily oral (p.o. via P20 pipette) Tam from either P2-P4 or P7-
P9.
Immunohistochemistry (IHC)
Brains were extracted, immersion-fixed in 4%
paraformaldehyde, and processed for slide-mounted and free-
floating IHC as previously described [31,37]. A freezing
microtome was used to collect 30 µm coronal sections
throughout the entire hippocampus in serial sets of 8 (for P14)
or 9 (for P21) for IHC to visualize immunoreactive(+) cells. The
following primary antibodies were used: chicken polyclonal
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anti-green fluorescent protein (GFP; 1:3000; Aves Labs,
Tigard, OR) [37]; mouse polyclonal anti-glial fibrillary acidic
protein (GFAP; 1:400; Millipore, Billerica, MA) [37]; mouse
polyclonal anti-oligodendrocyte (RIP; 1:200; Developmental
Studies Hybridoma Bank, DSHB, Iowa City, IA) [38,39]; mouse
polyclonal IgM anti-4D4 (1:40; DSHB, Iowa City, IA) [40]; rabbit
polyclonal anti-S100b (1:400; SWANT, Marly, Switzerland)
[37]; rabbit polyclonal anti-Ki67 (1:200; Thermo Scientific,
Rockford, IL) [37]; or rabbit polyclonal anti-activated caspase 3
(AC3; 1:500; Cell Signaling Technologies, Danvers, MA) [37].
All secondary antibodies (1:200) were from Jackson
ImmunoResearch, West Grove, PA, with exception for goat
anti-mouse IgM mu chain conjugated to DyLight 488 (1:200;
AbCam, Cambridge, MA).
For stereologic quantification of YFP+ or AC3+ cells and
qualitative and phenotypic analysis of YFP+ cells [31,37], slide-
mounted sections were pre-treated in citric acid and then
incubated with primary antibody against GFP overnight, with
subsequent 60 min incubations in biotin-conjugated secondary
antibody (1:250) and avidin-biotin complex (1:50; Vector
Laboratories, Burlingame, CA). Visualization was performed by
incubation with Tyramide-Plus signal amplification (1:50;
PerkinElmer, Boston, MA) for YFP+ cells, and DAB/metal
concentrate (10x; Thermo Scientific) for AC3+ cells. For
double- or triple-labeling and subsequent phenotypic analysis,
tissue was incubated with 2 primary antibodies (YFP and either
4D4 or S100b) or 3 primary antibodies (YFP, Ki67 and either
GFAP or RIP) on slide-mounted sections overnight. For
brightfield microscopy, slides were counterstained with Nuclear
Fast Red (Vector). For epifluorescent microscopy, slides were
counterstained with DAPI (1:5000; Roche). All slides were
dehydrated and coverslipped using DPX (Steinheim,
Germany).
Qualitative analysis, cell quantification, and phenotypic
analysis
To assess the efficacy of TOM or TOM-TOP in driving Tam-
induced Cre-mediated recombination in the brain, YFP-stained
brain sections from nestin-YFP mice were examined at low and
high magnification for presence or absence of YFP+ cells in
any region of the brain. For these pilot studies of TOM vs.
TOM-TOP efficacy, 3 litters were examined, with an average of
8 pups/litter.
To quantify YFP+ and AC3+ cells, stained brain sections
from WT and iCdk5 TOM-TOP mice were examined via an
observer blind to treatment group using published stereological
principles [41]. YFP+ cells were quantified in cortex, corpus
callosum (cc), and hippocampus, specifically in the stratum
oriens (Or), and stratum radiatum (Rad). AC3+ cells were
quantified in cortex. For both the cortex and corpus callosum,
the anterior–posterior boundary was defined by sections in
which the hippocampus was evident, plus “bookended”
sections (e.g. one section prior and one section subsequent to
the hippocampus). For the cortex, the medial-lateral boundary
was defined as the medial tip of the midsagittal sulcus to the
ventral lateral edge of the cortex. Therefore, cortical analysis
included the majority of the retrosplenial agranular, visual,
auditory, and entorhinal cortices and the posterior aspects of
the sensory, motor, and piriform cortices, but excluded medial
structures like the cingulate and retrosplenial granular cortices
and subcortical structures like the amygdala [42]. Cortical
analysis also included layers I-VI. For the corpus callosum, the
medial-lateral boundary was defined as the midsagittal or
medial appearance to the ventral lateral boundary. While the
cingulum was considered for corpus callosum analysis, regions
of the corpus callosum that were ventral and lateral to the
callosal bifurcation (e.g. near amygdala) were excluded. Data
are presented as total cells per region analyzed (mean
±standard error of the mean [s.e.m.]). For these studies –
which comprise most figures in this study – each time point and
genotype represents a minimum of 4-5 mice.
After stereological cell quantification, a subset of animals
(with average YFP+ cell counts, 3-4 mice per timepoint and
genotype) was selected for additional phenotypic analysis of
double-labeled cells. Phenotypic analysis was performed using
laser scanning confocal microscopy as previously described
[43,44] to assess the proportion of YFP+ cells in the cortex
were that were RIP+YFP+, GFAP+YFP+, S100b+YFP+,
4D4+YFP+, Ki67+YFP+, Ki67+GFAP+YFP+, and Ki67+RIP
+YFP. The glial antibodies (GFAP, RIP, S100b, and 4D4)
marked cell bodies, many which had characteristic glial
processes emerging from the soma. Colocalization, however,
was quantified only if the YFP+ and glial antibody signals
colocalized to the soma under three-dimensional/orthogonal
confocal Z-scan analysis. Phenotypic proportions were then
multiplied by total number of YFP+ cells (from stereology), and
the resulting data on the total number of double+ (or triple+)
cells per brain region are reported (mean±s.e.m.).
Volume quantification
Volume of the cortex and hippocampus was quantified using
the Cavalieri Probe within Stereo Investigator (MBF
Bioscience, MicroBrightField, Inc., Williston, Vermont) as
previously published [45,46]. For P14 and P21 brains, every 8th
(P14) or 9th section (P21) from -0.94 to -3.64 mm from Bregma
was analyzed to assess the size of the cortex and
hippocampus. The anatomical boundaries that were used to
quantify YFP+ cells in the cortex and hippocampus were also
applied for Cavalieri volume measurements. The region of
interest was viewed and volume was determined using an
Olympus BX51 microscope with a MicroFIRE A/R camera
(Optronics, Goleta, California) and 10x, NA 0.30 lens. Area
sizes were determined using the area measurement tool
(based on the Cavalieri estimator) in which an automated grid
of test points was superimposed upon the region of interest.
Area was estimated from the total number of points that fell
within the respective field. To obtain the volume, the sum of the
areas measured was multiplied by the sampling fraction (8 for
P14 and 9 for P21) and the section thickness (30µm). The
Gunderson coefficient of variance for each mouse quantified
was always less than 10%. Data are reported as the total
estimated volume (mm3) of the cortex and hippocampus per
brain and are presented as mean±s.e.m.
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Statistical analysis
The experiments were designed to specifically assess the
role of Cdk5 in postnatal development. Therefore, the primary
comparisons of interest were between WT and iCdk5 mice at
each timepoint. Therefore, unless specified otherwise, data
were compared with an unpaired Student’s t-test between WT
and iCdk5 mice at a given timepoint (e.g. Tam P2-P4, kill P14).
Significance value was set at p<0.05 and indicated as an
asterisk. Significance value at p<0.07 is indicated by a pound
sign.
Results
Administration of Tam to mothers and to pups is an
effective approach to induce genetic deletion in nestin-
lineage cells
To study the role of Cdk5 in early postnatal development
while leaving embryonic development intact, we first
established that we could initiate recombination in the early
postnatal brain. We compared Tam administration to nestin-
YFP mothers (TOM) to Tam administration to nestin-YFP
mothers and their P2-P4 pups (TOM-TOP; Figure S1). Our
readout for these initial studies was the presence of YFP+ cells
in the brain of nestin-YFP mice, a sign of Tam-induced Cre-
mediated recombination in nestin-expressing cells. The
qualitative analysis revealed that TOM (given P2-P4, kill P21)
resulted in YFP+ cells in only 60% of pups in a litter with YFP+
brain cells (Figure S1A), while TOM-TOP P2-P4 resulted in
100% of pups in a litter. Thus, all other experiments presented
here utilized the TOM-TOP approach.
With the TOM-TOP paradigm, both Cdk5 WT (nestin-
CreERT2/R26R-YFP/Cdk5wt/wt) and iCdk5 mice (nestin-
CreERT2/R26R-YFP/Cdk5flox/flox) had normal weight gain over
time with Tam P2-P4 (Figure S1B) or Tam P7-P9 (Figure S1C).
Both mice had normal body and overall brain development, and
displayed normal general activity until time of kill (data not
shown). Thus, unlike constitutive deletion of Cdk5 [47], deletion
of Cdk5 from nestin-expressing cells in the early postnatal
period has no overt effect on indices of general health. Given
the efficacy and safety of the TOM-TOP approach, all
subsequent experiments used TOM-TOP, indicated as “Tam
P2-P4” or “Tam P7-P9”.
Inducible deletion of Cdk5 in nestin-lineage cells (Tam
P2-P4) results in fewer YFP+ glial cells in cortex
Having established the general efficacy and safety of giving
Tam via TOM-TOP, we began our cellular investigation into the
role of Cdk5 in nestin-lineage cells during postnatal
development. We first performed a qualitative examination of
YFP+ cell distribution in the brains of WT and iCdk5 mice given
Tam P2-P4 and killed at P14 or P21, with an emphasis on
gross distribution in WT brains (Figure 1A–E). At both P14 and
P21 there were YFP+ cells in the gliogenic regions of the brain
– cortex, hippocampus, and corpus callosum. In addition, there
were relatively fewer cells evident at P21 compared to P14,
although our experimental design did not allow statistical
analysis of this impression. This qualitative distribution of YFP+
cells fits with the known contribution of nestin-lineage cells to
development of these brain regions during the postnatal period.
Given that the cortex completes cytogenesis and migration
prior to the hippocampus [48], the cortex was the first focal
point of our analysis of YFP+ cell number and phenotype. We
hypothesized that inducible deletion of Cdk5 from nestin-
lineage cells would result in fewer YFP+ cortical cells, as
predicted from the role of Cdk5 during earlier and later periods
of development in the cortex and other brain regions [20]. In
keeping with our hypothesis, quantitative analysis showed that
inducible deletion of Cdk5 from nestin-lineage cells (Tam P2-
P4) resulted in fewer YFP+ cortical cells than in WT littermates
when examined 2-3 weeks later (Figure 1F). There was a
strong trend towards fewer YFP+ cells in iCdk5 vs. WT
littermates at P14 (p=0.06), and significantly fewer YFP+ cells
in iCdk5 vs. WT littermates at P21 (p<0.05). These data show
that inducible deletion of Cdk5 from nestin-lineage cells during
a period of active cortical development and gliogenesis
decreases the number of YFP+ progeny in the cortex 2-3
weeks later.
Given the ongoing gliogenesis in the postnatal cortex
[6,11,15], we next hypothesized inducible deletion of Cdk5 from
nestin-expressing cells would result in fewer YFP+ cortical glial
cells. Indeed, the YFP+ cortical cells presented a variety of
morphologies, including oligodendrocytic and astrocytic cells
but rarely neurons (Figure 1B–E), in keeping with data that
nestin-lineage cells generate to glia in the developing cortex.
Phenotypic analysis of YFP+ cortical cells in P14 WT mice
given Tam P2-P4 revealed that about one-third of YFP+ cells
expressed a marker of astrocytes, GFAP+ (Figure 1G–I)
[49,50], and one-third expressed a marker of oligodendrocytes,
RIP (Figure 1K–M) [51,52]. In P21 WT mice given Tam P2-P4,
the GFAP+YFP+ proportion was lower than the RIP+YFP+
proportion (Figure 1H vs. 1L). By multiplying these proportions
with the absolute number of YFP+ cell number from the
stereologic assessment [37], a picture emerged of the dynamic
and ongoing astrogenesis and oligodendrogenesis in the WT
mouse cortex (Figure 1I vs. 1M). At P14, there were roughly
equal numbers of GFAP+YFP+ astrocytes and RIP+YFP+
oligodendocytes. At P21, there were fewer GFAP+YFP+
astrocytes than RIP+YFP+ oligodendrocytes. These results in
WT mice confirm that – as suggested using other inducible
mice and other peri- and postnatal time points for induction –
nestin-expressing cells give rise to oligodendrocytes and
astrocytes during the first postnatal week in mice.
Having established the distribution of the glial phenotypes of
nestin-lineage cortical cells in WT mice, we next examined the
distribution of glial phenotypes after inducible deletion of Cdk5
from nestin-lineage cells (Tam P2-P4). Proportionally, there
was a lower percentage of RIP+YFP+ cells in iCdk5 vs. WT
mice at both P14 and P21 (Figure 1L), with no similar shift in
GFAP+YFP+ cells (Figure 1H) or YFP+ cells positive for
another astrocytic marker, a calcium-binding protein S100b
(proportional data not shown) [53]. Multiplication of these
proportional data by the total respective cell numbers revealed
fewer GFAP+YFP+ at P21 (Figure 1I; along with a non-
significant trend at P14) and fewer S100b+YFP+ cells at P21
(Figure 1J) in iCdk5 vs. WT mice at P21, while there were
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Figure 1.  Inducible deletion of Cdk5 in nestin-lineage cells (Tam P2-P4) results in fewer YFP+ glial cells in cortex.  (A)
Paradigm of Tam administration. Representative images for brain sections stained for YFP at P14 (B, C) and at P21 (D, E) show
YFP+ cells in the cortex, corpus callosum (cc), and stratum oriens (Or) of the hippocampus in the WT (top) and iCdk5 littermates
(bottom; scale bar, s.b.=100 µm). (F) Stereological quantification of YFP+ cells in the cortex. (G) Representative microphotograph of
cortex shows YFP+ cells (red) overlapping with GFAP (green; closed arrowheads) or with GFAP and Ki67 (blue; open arrowhead;
s.b.=20 µm). (H) Percent of YFP+ cortical cells expressing both GFAP and YFP. (I) Total number of GFAP+YFP+ cortical cells. (J)
Total number of S100b+YFP+ cortical cells at P21. Inset shows double-positive cells (arrowheads; s.b.=10 µm). (K) Representative
image of cortex shows YFP+ cells (red) overlapping with RIP alone (green; arrowhead), or with RIP and Ki67 (arrow; s.b.=20 µm).
(L) Percent of YFP+ cortical cells expressing both RIP and YFP. (M) Total number of RIP+YFP+ cortical cells. (N) Total number of
4D4+YFP+ cortical cells at P21. Inset shows double-positive cells (arrowheads; s.b.=10 µm). (O) Total number of Ki67+YFP+
cortical cells. (P) Total number of RIP+Ki67+YFP+ cortical cells. (Q) Total number of AC3+ cortical cells (inset shows two AC3+
cells; s.b.=10 µm).
doi: 10.1371/journal.pone.0072819.g001
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fewer RIP+YFP+ cells in iCdk5 vs. WT mice at both P14 and
P21 (Figure 1M). This reduction in number of mature
astrocytes and oligodendrocytes in iCdk5 vs. WT was mirrored
by reduction in number of YFP+ cells labeled for a marker of
oligodendrocyte-astrocyte precursors, 4D4 (Figure 1N) [40,54].
One possible explanation for reduced gliogenesis in iCdk5
mice is reduced cortical volume. However, the total volume of
the cortex did not differ between WT and iCdk5 at P14
(mean[mm3] ±s.e.m WT: 35.3±2.2; iCdk5: 35.8±3.5; p>0.05) or
at P21 (WT: 37.7±1.9; iCdk5: 41.9±1.6; p>0.05). Moreover,
when the total cortical volume was factored into the total
number of GFAP+YFP+ astrocytes and RIP+YFP+
oligodendrocytes, there was an identical reduction in
astrogenesis and oligodendrogenesis as seen in Figure 1I and
1M (data not shown). Thus, inducible deletion of Cdk5 in
nestin-lineage cells from P2-P4 results in fewer YFP+
astrocytes and oligodendrocytes in the cortex without
significantly changing cortical volume when examined 2-3
weeks later.
Inducible deletion of Cdk5 in nestin-lineage cells (Tam
P2-P4) results in fewer YFP+ proliferative cells in cortex
The reduction in cortical YFP+ astrocytes and
oligodendrocytes in iCdk5 vs. WT mice could be due to many
underlying mechanisms, including impaired proliferation or
increased cell death. To address the possibility that inducible
deletion of Cdk5 in nestin-lineage cells impaired proliferation in
the cortex (Tam P2-P4), we examined the proportion of YFP+
cells that expressed Ki67, an endogenous proliferation marker
of neuronal and glial precursors [55–57], and then calculated
the number of Ki67+YFP+ cortical cells (Figure 1O). At P14,
there was an apparent trend towards fewer Ki67+YFP+ cortical
cells in iCdk5 vs. WT mice but this was not significant (p>0.6).
However, at P21 iCdk5 mice presented 70% fewer Ki67+YFP+
cells than WT mice (Figure 1O). Moreover, since total cortical
volume was not significantly different between iCdk5 and WT
mice at P14 or P21 (see above), the proportional reduction of
Ki67+YFP+ cortical cells in iCdk5 vs. WT mice with respect to
total cortical volume remained identical (data not shown). To
phenotype these Ki67+YFP+ cells, we examined their
colocalization with GFAP or RIP. We observed almost no
GFAP+Ki67+YFP+ cells in either WT or iCDK5 mice. However,
there was a greater than 90% reduction in RIP+Ki67+YFP+
cells in iCDK5 mice vs. WT at P21 (Figure 1P), with a trend
towards a decrease seen at P14. To address the companion
possibility – that inducible deletion of Cdk5 in nestin-lineage
cells increased cell death – we examined the total number of
cortical cells that expressed AC3, a marker of apoptosis [58].
However, WT and iCdk5 mice did not differ in the number of
cortical AC3 cells at either P14 or P21 (Figure 1Q). Taken
together, these data show that inducible deletion of Cdk5 in
nestin-lineage cells via Tam P2-P4 decreased YFP+
astrocytes, oligodendrocytes, and proliferative cells in the
cortex.
Inducible deletion of Cdk5 in nestin-lineage cells (Tam
P2-P4) also results in fewer YFP+ cells in other
gliogenic regions
Having established that loss of Cdk5 from nestin-lineage
cells via Tam from P2-P4 led to fewer cortical YFP+ astrocytes
and oligodendrocytes, we turned our attention to 2 other
regions of ongoing gliogenesis: the hippocampus and corpus
callosum (Figure 2A–E). The reduction in the number of YFP+
glial cells in the cortex was mirrored in the hippocampus, where
2 layers in the Cornu Ammon’s (CA1) region of the
hippocampus had fewer YFP+ cells. Both the stratum oriens
(Or; Figure 2F) and the stratum radiatum (Rad; Figure 2G) had
fewer YFP+ cells in iCdk5 mice relative to WT littermates. The
YFP+ cells in the CA1 region presented an astrocytic-like
morphology (Figure 2G), similar to the YFP+ cortical
astrocytes. Similar to the cortex, the reduction in YFP+ cells in
the hippocampus of iCdk5 mice was not due to smaller
hippocampal volume, as the total hippocampal volume did not
differ between WT and iCdk5 mice at P14 (WT: 13.3±0.8;
iCdk5: 13.2±1.2; p>0.05) or P21 (WT: 13.7±1.6; iCdk5:
14.7±1.8; p>0.05). In addition there were fewer YFP+ cells in
the corpus callosum of iCdk5 vs. WT mice at P14 (Figure 2H),
but no significant difference AC3+ cells in the corpus callosum
(WT: 598.9±89.4; p>0.05; iCdk5: 512±111.0; p>0.05). Taken
together, these results show inducible deletion of Cdk5 from
nestin-lineage cells via Tam P2-P4 results in fewer YFP+ cells
in the cortex, corpus callosum, stratum oriens, and stratum
radiatum regions of CA1 when examined 2-3 weeks later.
In contrast to the effects via Tam P2-P4, inducible
deletion of Cdk5 in nestin-lineage cells via Tam P7-P9
does not change YFP+ cell number in hippocampal or
cortex
Since inducible deletion of Cdk5 from nestin-lineage cells via
Tam P2-P4 influenced YFP+ cells in ongoing regions of
gliogenesis, we hypothesized deletion of Cdk5 from nestin-
lineage cells after cessation of most gliogenesis would result in
no change in YFP+ cell numbers. To test this, mice were given
Tam via Tam P7-P9 and killed P14 or P21 (Figure 3A), and the
hippocampus and cortex were stereologically examined for
YFP+ cells (Figure 3B–E). Unlike inducible deletion of Cdk5 via
Tam P2-P4, there was no difference between WT and iCdk5
mice in the number of YFP+ cells in CA layers (Or, Figure 3F;
Rad, Figure 3G), although there was a non significant trend
towards more YFP+ Or cells at P14. In addition, there was no
difference between WT and iCdk5 mice in the number of YFP+
cells in the cortex (Figure 3H) and the corpus callosum (Figure
3I). When taken together, the Tam P2-P4 and Tam P7-P9
experiments suggest that postnatal generation of astrocytes
and oligodendrocytes from nestin-lineage progenitors are
largely restricted to the first week after birth.
Discussion
While much is known about glial and neuronal development
during embryogenesis [4,5,59], far less is known about the in
vivo regulation of glia during the early postnatal period. It is not
clear what molecular and genetic factors determine how
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astrocytes and oligodendrocytes populate the brain during the
first weeks of postnatal life in mice. It is also unclear if the
many key transcription factors, growth factors, and genetic
regulators in embryogenesis are also important during the early
postnatal period. An example of a protein having discrete,
developmental-stage specific roles is Cdk5. Cdk5 was initially
thought to be specific for neuronal development during
embryogenesis [47], but subsequent studies revealed its role in
many non-neuronal cells [33,60]. Despite recent progress in
understanding non-neuronal Cdk5 functions [61–63], it is not
clear if and how Cdk5 is involved in development of astrocytes
and oligodendrocytes in vivo, especially in the early postnatal
period. At least 2 obstacles prevented prior exploration of the
Figure 2.  Inducible deletion of Cdk5 in nestin-lineage cells
results in fewer YFP+ cells in the hippocampus and corpus
callosum.  (A) Paradigm of Tam administration.
Representative images of the brain at P14 (B, C) and P21 (D,
E) at P14 in WT (top) and iCdk5 littermates (bottom)
highlighting cortex, corpus callosum (cc), and hippocampus
with stratum oriens (Or), CA1, stratum radiatum (Rad) and
molecular layer (Mol, s.b.=100 µm). Total number of YFP+ cells
in Or (F), Rad (G; inset shows typical YFP+ Rad cell at P14,
s.b.=10 µm), and cc (H).
doi: 10.1371/journal.pone.0072819.g002
regulation of postnatal gliogenesis by Cdk5. First, constitutive
knockouts of Cdk5 or its activators, like p35, display increased
perinatal mortality and severe developmental abnormalities
[29,47,64], which complicates interpretation of effects specific
Figure 3.  Inducible deletion of Cdk5 in nestin-lineage cells
via Tam P7-P9 does not change YFP+ cell number in
hippocampus or cortex.  (A) Paradigm for Tam
administration. Representative images of YFP-stained
hippocampi from P14 (B, C) and P21 (D, E) show YFP+ cells in
corpus callosum (cc), stratum oriens (Or) and radiatum (Rad) in
WT (top) and iCdk5 littermates (bottom; scale bar, s.b.=100
µm). Stereological quantification of YFP+ cells in the Or (F),
Rad (G), cortex (H) and cc (I).
doi: 10.1371/journal.pone.0072819.g003
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to postnatal period. Second, until recently [21,32], there was a
lack of appropriate inducible Cdk5 knockout mouse models that
would allow temporal and specific deletion within a discrete cell
population during early postnatal period when gliogenesis
predominantly occurs.
We used an inducible knockout of Cdk5 in nestin-expressing
cells and their progeny [21,31] to clarify the role of nestin-
expressing cells in gliogenesis in early postnatal life, and to
examine the role of Cdk5 in postnatal gliogenesis from nestin-
expressing progenitors in vivo. As discussed below, our results
confirm and extend prior work that astrocytes and
oligodendrocytes are generated from nestin-expressing
progenitors during the first postnatal week. Our results also
show that Cdk5 in nestin-expressing progenitors are important
for proper development of astrocytes and oligodendrocytes in
early postnatal life.
Nestin-expressing progenitors generate astrocytes and
oligodendrocytes during first postnatal week
A large body of evidence shows that astrocytes and
oligodendrocytes are generated during the early postnatal
period [5]. Oligodendrocyte progenitors migrate into the cortex
and other brain regions in 3 waves, with the first beginning at
E12.5 [11,12] and the last wave occurring during the first
postnatal week from the hippocampal subventricular region [6]
that hosts nestin-expressing progenitors [15]. Astrocytic
migration is less clear, likely because hallmark antigens such
as GFAP or S100beta label both putative progenitors and
mature astrocytes [4]. It is also unclear what role nestin-
expressing progenitors have in glial development during early
postnatal development. Certainly, nestin-expressing
progenitors give rise to neurons and radial glial cells during
embryogenesis, and to a small number of neurons in discrete
regions of the adult brain [5]. However, prior to our study
presented here, the contribution of nestin-lineage progenitor
cells towards the generation of astrocytes and
oligodendrocytes during early postnatal development was not
clear.
To this end, we utilized nestin-CreERT2/R26R-YFP mice for
lineage tracking of YFP+ cells derived from nestin-expressing
progenitors. We show that glial generation from nestin-lineage
progenitors is confined to the first postnatal week, as we
observe more than 50-fold decrease in YFP+ cells in P21
cortex between earlier Tam administration at P2-P4 and later
Tam administration at P7-P9. These results support prior work
showing that both oligodendrocytes and astrocytes are
generated from nestin-expressing cells [15,65] and in roughly
equal numbers. While our data is largely confirmatory –
agreeing with prior work showing that a significant source of
early postnatal astrocytes and oligodendrocytes is nestin-
expressing progenitor cells – they also extend prior work in
important ways. For example, prior work showed continuous
cortical postnatal gliogenesis during the first postnatal week by
tracking implanted cells [14] or lineage-tracking in transgenic
mice [11]. These tracked cells presented some challenges, in
that they were exogenous [14], or were difficult to distinguish
from cells generated during embryogenesis [11], and none of
the prior work enabled distinction between local generation of
astrocytes in the early postnatal cortex [10] from those that
may migrate into the region. Therefore, a major benefit of our
current approach is to demonstrate the efficacy of temporally-
specific lineage-tracking, allowing specification of the
generation of oligodendrocytes and astrocytes from nestin-
expressing progenitors only during the first postnatal week.
This sets the stage for future work that can address the specific
cellular source or migration pattern of astrocytes vs.
oligodendrocytes in the early postnatal period, for example, by
using nestinCreERT2/R26R-YFP transgenic mice along with
shorter survival times after Tam.
Oligodendrocytes and astrocytes derived from nestin-
expressing cells rely on Cdk5
In both embryonic and adult development, Cdk5 controls cell
migration, differentiation, synaptic plasticity, and the cell cycle
[33]. However, the in vivo role of Cdk5 in early stages of
postnatal gliogenesis was previously unknown. Here we find
that inducible deletion of Cdk5 from nestin-expressing cells
during the early postnatal period ultimately results in fewer
recombined astrocytes and oligodendrocytes. The decrease in
recombined glial cells was seen in 3 regions undergoing
gliogenesis – the cortex, CA1 hippocampal region, and corpus
callosum – suggesting this is not a region-specific
phenomenon. There may be, however, a cell type-specific role
for Cdk5 in gliogenesis. For example, the decrease in
recombined GFAP+ astrocyte number takes longer to appear
relative to recombined RIP+ oligodendrocytes. Specifically, we
observed only a trend towards fewer YFP+ astrocytes in iCdk5
vs. WT mice at P14, but significantly fewer YFP+
oligodendrocytes at P14. The mechanism for this cell-specific
reduction may differ between the two glial cell types. For
example, at P21 there is a reduction in both GFAP+ and RIP+
cell types, but in oligodendrocytes there may be impaired cell
fate/maturation as well. These results also support recent
findings that astrocytes can also be generated locally in the
postnatal cortex [10], which could contribute to the prolonged
time required to observe fewer recombined GFAP+ astrocytes
in iCdk5 mice. It is also possible that Cdk5 may have distinct
roles for regulating proliferative and post-mitotic astrocytes
during gliogenesis. However, as additional astrocytic markers
such as GLAST, GFAP, and S100b can label both post-mitotic
astrocytes and astrocytic progenitors [4], it remains unclear
from our study how Cdk5 deletion may differentially affect
proliferative and post-mitotic astrocytes. Further complicating
matters, there is limited consensus as to which cell lineage
astrocytes follow during their development [66–70]. Therefore,
future experiments are needed to assess in more detail the role
of Cdk5 on proliferating vs. post-mitotic astrocytes.
What could be the possible molecular and cellular
mechanisms underlying how Cdk5 supports early postnatal
gliogenesis from nestin-expressing progenitors? Cdk5 controls
key cytoskeleton elements – such as actin-related proteins [71]
or GFAP [24,25] – to adjust the intracellular machinery during
differentiation and maturation. Such a role for Cdk5 in
differentiation was observed in neurons generated from nestin-
expressing progenitors in adult hippocampus [21], and applies
for differentiation of oligodendrocytes as well. Cdk5 activity
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increases during the differentiation of oligodendrocyte
progenitors in vitro [26] to phosphorylate cytoskeletal proteins
critical for differentiation and/or migration such as WAVE2 [28]
and paxillin [27]. While we cannot rule out that the reduction in
number of oligodendrocytes in our results is due to impaired
differentiation, our observation of fewer Ki67+RIP+ cells
suggest that the deficit in iCdk5 mice is due to reduced
proliferation. However, Cdk5 may not directly control cell cycle
[33] but rather may indirectly affect cell cycle and proliferation
[72]; thus, our observation of reduced proliferation is most likely
not directly downstream of Cdk5.
In addition to proliferation and differentiation, Cdk5 may also
support postnatal gliogenesis by regulating glial migration
[20,28,60]. Given the role of Cdk5 in neuronal migration
[19,63], the normal pattern and/or timing of glial migration could
also be disturbed in iCdk5 mice. Understanding possible glial
migrational roles of Cdk5 in nestin-lineage progenitors would
reveal common or divergent roles for this regulator in neurons
vs. glial cells, similar to what has been found using in vivo
[19,20,73] and in vitro [26–28] migrational assays. Future
experiments examining the role of Cdk5 in early postnatal glial
migration of nestin-expressing progenitors as well as the
biochemical and molecular underpinnings of its role would
therefore require separate, comprehensive study employing in
vivo, in vitro, and ex vivo strategies [20,62,74–79]. It is also
possible that in addition to impaired proliferation, differentiation/
maturation, and migration, early deficits in the nestin-
expressing progenitors may contribute to the iCdk5 phenotype.
This is plausible, since Cdk5 can phosphorylate both GFAP
and nestin, cytoskeletal proteins expressed in both astrocytes
and neural progenitors [15,25,50,80].
In summary, our results demonstrate that nestin-expressing
progenitors are capable of generating astrocytes and
oligodendrocytes in different brain regions during a critical
period of the first postnatal week in mice. Our results also show
that Cdk5 is required for the proper early postnatal gliogenesis
in vivo. As the number of cellular processes regulated by Cdk5
increases, and Cdk5 is implicated in neuron-glia interaction as
a part of etiology of neurodegenerative diseases [24,33,81],
these findings will help us better understand the role of Cdk5 in
development of non-neuronal brain cells.
Supporting Information
Figure S1.  Influence of Tamoxifen (Tam) administration to
lactating mothers (TOM) and to mothers and pups (TOM-
TOP) on Cre-mediated recombination and body weight. In
TOM experiments, only mothers received Tam (see Methods).
In TOM-TOP experiments, Tam was administered orally to
pups and their mothers (i.p.) once a day from P2-P4 or P7-P9.
(A) The percent of nestin-YFP offspring from TOM vs. TOM-
TOP litters that had evidence of recombination (e.g. YFP+ cells
in any brain region) is 100% in TOM-TOP mice, but lower in
TOM mice. Shown are data from Tam P2-P4 and kill P21. (B,
C) TOM-TOP does not negatively influence normal progression
of body weight in WT and iCdk5 littermates given Tam from
either P2-P4 (B) or P7-P9 (C).
(TIFF)
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